ArticleJournal of clinical practice and research2026
Intravenous Thrombolysis for Stroke in First-Trimester Pregnancy: A Case Report.
Article in Journal of clinical practice and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The use of thrombolytic therapy during pregnancy remains a source of concern and stress. In pregnant patients who meet the criteria, thrombolytic therapy is recommended when the expected benefits outweigh the risks. Case Report: A 33-year-old pregnant woman in her first trimester presented with an acute-onset impairment of speech and comprehension. Her initial National Institutes of Health Stroke Scale score was 4. Diffusion MRI was compatible with cortical-subcortical acute ischemia in the left frontotemporal region. Intravenous thrombolytic therapy was administered to the patient who met the criteria for thrombolysis. No bleeding or other complications were observed after treatment. On examination, after one week, all symptoms had completely resolved. The pregnancy ended in fetal abortion at 16 weeks; the cause was not determined. Conclusion: Publication of case reports on the complications and efficacy of IVT during pregnancy is important, since there are no controlled studies of thrombolytic therapy in pregnant women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.